Trials / Recruiting
RecruitingNCT05804916
Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer
A Single-center, Blinded, Efficacious, Phase III Randomized Clinical Trial Initiated by Investigators to Investigate the Use of Surface Guided Radiation Therapy (SGRT) in Combination With Deep Inspiration Breath Hold (DIBH) Technique for Left Breast Cancer Treatment, Compared to Traditional Laser Alignment With Free Breathing Treatment
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 556 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is a single-center,blinded, efficacious, phase III randomized clinical trial initiated by investigators. The primary objective is to investigate the use of Surface Guided Radiation Therapy (SGRT) in combination with Deep Inspiration Breath Hold (DIBH) technique for left breast cancer treatment, compared to traditional laser alignment with free breathing treatment. This approach offers superior positioning accuracy and improved heart protection without any increase in radiation or adverse reactions.
Detailed description
This is an investigator-initiated blinded, efficacious, phase III randomized clinical trial study. The study hypothesis is that the use of Surface Guided Radiation Therapy (SGRT) in combination with the Deep Inspiration Breath Hold (DIBH) technique for left breast cancer treatment can improve positioning accuracy and heart protection without any increase in radiation or adverse reactions. The primary endpoint of this study is the accuracy of the treatment location and incidence of patient coronary events/myocardial perfusion decline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Surface Guided Radiation Therapy (SGRT) | SGRT and DIBH those two devices could be combined together to improve the accuracy in radiation therapy position and heart protection |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2027-04-01
- Completion
- 2027-04-01
- First posted
- 2023-04-07
- Last updated
- 2023-04-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05804916. Inclusion in this directory is not an endorsement.